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Figure 1. In vitro and in vivo anti-sarcoma activity of IGF-1R and ROR1 CAR T cells. (A) Cytotoxicity assays. (B) Anti-sarcoma activity in a systemic model. SaOS2-
fﬂucN cells (7.5105) were i.v. injected into NSG mice for 5 days, treated with mock, IGF-1R CAR and ROR1 CAR T cells (1107) on day 6 and 9, and imaged for tumor
control on day 11, 17, 24, 31 and 38. (C) Survival beneﬁt of CAR T cells in a local sarcoma model. SaOS2-fﬂucN (3105) cells were i.p. injected in NOD/SCID mice,
untreated or treated with mock, IGF-1R (IGZ) CAR and ROR1 CAR T cells on day 3, 5 and 7, and monitored for survival.
Abstracts / Biol Blood Marrow Transplant 20 (2014) S184eS210 S185expressed in certain types of cancer but not in normal adult
tissues. Multiplex cytokine assays showed that both IGF-1R
and ROR1 CAR T cells produced high levels of IFN-g, TNF-a
and IL-13 in an antigen-speciﬁc manner. Furthermore, both
IGF-1R and ROR1 CAR T cells were generated from 3 sar-
coma patients and were shown to release signiﬁcant
amounts of IFN-g in response to stimulation with cultured
allogeneic sarcoma lines. The in vivo adoptive transfer of
both IGF-1R and ROR1 CAR T cells derived from a sarcoma
patient signiﬁcantly reduced tumor growth and prolonged
the survival of animals in both pre-established, systemic
(i.v.) and local (i.p.) osteosarcoma xenograft models (Fig. 1B
and 1C). Taken together, these data indicate that both IGF-
1R and ROR1 can be effectively targeted by CAR T cells and
that such CAR T cells may be useful in the treatment of
metastatic or refractory sarcomas.STEM CELL BIOLOGY
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Background: RDEB is a severe inherited skin blistering dis-
ease caused by mutations in the COL7A1 gene that encodes
type VII collagen (C7), a major component in the anchoring
ﬁbrils at the basement membrane. Allogeneic stem cell
transplantation in both experimental animals and human
subjects with RDEB resulted in increased C7 deposition and
alleviation of the blistering phenotype in some recipients
(Kiuru/Cairo/Christiano et al. 2011). However, there was no
distinct anchoring ﬁbril formation in the recipient skin and
the effective cell types that contribute to the regeneration in
RDEB skin remain to be identiﬁed. Our previous studies
demonstrated that CB-derived USSCs express C7 and pro-
mote epithelialization and wound closure in a murine
wound healing model (Liao/Cairo et al. 2013).
Methods: CB-derived USSCs were labeled with GFP/Luc re-
porter gene and injected in newborn col7a1-/- (RDEB) mice
without immunosuppression. The migration of USSCs was
determined by bioluminescent imaging (BLI) of RDEBmice as
well as excised internal organs.
Results: A single intra-hepatic injection of USSCs (0.2 x 106)
in newborn RDEB mice arrested the blistering phenotype
and signiﬁcantly enhanced the median survival to 8 days
Fig 2. A. Time course BLI on a representative RDEB mouse that received USSC inject
stomach and digestive system, 4, pancreas, 5, spleen, 6, heart and 7, kidney.
Fig 1. A. Kaplan-Meier curve comparison between untreated and a single
USSC intrahepatic injection, repeated intra-hepatic USSC injection, a single
subcutaneous USSC injection and USSC conditioned medium injection.
P<0.0001. B. Disappearance of hemorrhagic blisters in the paws of a repre-
sentative RDEB mouse skin following USSC treatment.
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(n¼18) (P<0.0001)). About 30% of the USSC- treated mice
lived beyond 2 weeks of life span (Fig 1). A second USSC
intra- hepatic injection further elongated the median life
span (16 days, n ¼ 18, P<0.0001). Remarkably, two mice that
received repeated injections survived more than 12 weeks.
As compared to intra-hepatic injection of USSCs, other
methods, i.e., a single intradermal injection of USSCs (n¼15)
and multiple facial vein injections of USSC-conditioned
medium (n¼17) did not result in a longterm beneﬁt in the
recipient RDEB mice, although the median life span was
signiﬁcantly increased to 4 days and 3 days respectively
(P<0.0001). The data suggest that circulation of the USSC
cell population was necessary for the longterm survival of
RDEB mice. Histological analysis on the footpad skin of the
RDEB mice after a single intra-hepatic USSC injection
demonstrated that the percentage of the skin with intact
epidermis-dermis attachment was signiﬁcantly improved.
USSC injection also enhanced the expression of C7 in the
recipient skin and electron microscopy revealed a partial
restoration of anchoring ﬁbrils in skin biopsies from the
USSC-treated RDEB mice. BLI of the RDEB mice following
USSC injection further demonstrated that USSCs rapidly
went into circulation after intra-hepatic injection and did
not result in detectable retention in organs such as heart,
kidney, spleen etc (Fig 2). Indeed, speciﬁc localization of
USSCs was observed in the blistered paws and GI tracts,
suggesting a speciﬁc migration of USSCs toward the sites of
blisters.
Conclusion: CB-derived USSCs represent a novel stem cell
source for the treatment of RDEB.ion. B. Imaging of dissected internal organs on days 0 and 2.1, liver. 2, lung, 3,
